Integration bias of gammaretrovirus vectors following transduction and growth of primary mouse hematopoietic progenitor cells with and without selection.

Molecular Therapy : the Journal of the American Society of Gene Therapy
Mari AkerDavid W Emery

Abstract

The recent recognition that recombinant retrovirus vectors can induce oncogenic transformation has stimulated much interest in the pattern of vector integration sites. We report here on the integration pattern of a gammaretrovirus reporter vector following transduction and ex vivo culture of primary mouse bone marrow progenitor cells in the absence and presence of drug selection. Using a novel method of cloning junction fragments, we observed no bias for integrations within genes, but did observe a bias for integrations within gene-dense regions and especially near transcriptional start sites of highly active genes, similar to previous reports in other cell types. We also document a novel bias for integrations within or near a class of genes that encode nuclear-localized proteins. We found that drug selection resulted in an increase in the frequency of recovered integration events that were located within the beginning of genes, integration events that were located in less gene-dense regions, and integration events that were oriented in an antisense direction relative to flanking gene transcription. Taken together, these studies provide new insights into the nature of retrovirus vector integration patterns in primary cells and ...Continue Reading

References

Jul 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·D W EmeryG Stamatoyannopoulos
Apr 20, 2002·Science·Zhixiong LiChristopher Baum
May 7, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Evangelia YannakiDavid W Emery
Aug 20, 2002·Nature Genetics·Takeshi SuzukiNeal G Copeland
Aug 31, 2002·Cell·Astrid R W SchröderFrederic Bushman
Aug 9, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Donald B KohnUNKNOWN American Society of Gene Therapy (ASGT)
Dec 19, 2003·Nucleic Acids Research·Keiko AkagiNeal G Copeland
Jan 27, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Christopher BaumDavid A Williams
Feb 24, 2004·The Journal of Gene Medicine·Michael D Milsom, Leslie J Fairbairn
Jul 13, 2004·Nature Genetics·Cheol-Koo LeeJason D Lieb
Oct 14, 2004·Journal of Virology·Anna NarezkinaRichard A Katz
Jan 29, 2005·Proceedings of the National Academy of Sciences of the United States of America·Alan Engelman
Mar 4, 2005·Molecular and Cellular Biology·Stephen R YantMark A Kay
Apr 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Alexander G Holman, John M Coffin
Jan 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Grant D TrobridgeDavid W Russell

❮ Previous
Next ❯

Citations

Feb 26, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Chang Long LiDavid W Emery
Apr 9, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Danilo D'ApolitoSantina Acuto
Oct 5, 2010·Expert Reviews in Molecular Medicine·Evangelia YannakiGeorge Stamatoyannopoulos
Jan 1, 2010·Viruses·Sébastien Desfarges, Angela Ciuffi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.